A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection

A vaccine candidate to SARS-CoV-2 was constructed by coupling the viral receptor binding domain (RBD) to the surface of the papaya mosaic virus (PapMV) nanoparticle (nano) to generate the RBD-PapMV vaccine. Immunization of mice with the coupled RBD-PapMV vaccine enhanced the antibody titers and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivera-Ugarte, Santa-Mariela, Bolduc, Marilène, Laliberté-Gagné, Marie-Ève, Blanchette, Léa-Jeanne, Garneau, Caroline, Fillion, Maude, Savard, Pierre, Dubuc, Isabelle, Flamand, Louis, Farnòs, Omar, Xu, Xingge, Kamen, Amine, Gilbert, Mégan, Rabezanahary, Henintsoa, Scarrone, Martina, Couture, Christian, Baz, Mariana, Leclerc, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287509/
https://www.ncbi.nlm.nih.gov/pubmed/35850421
http://dx.doi.org/10.1016/j.nano.2022.102584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287509/
https://www.ncbi.nlm.nih.gov/pubmed/35850421
http://dx.doi.org/10.1016/j.nano.2022.102584

Ejemplares similares